Rosalind Advisors as of March 31, 2026
Portfolio Holdings for Rosalind Advisors
Rosalind Advisors holds 38 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Delcath Systems Com New (DCTH) | 12.3 | $31M | 3.3M | 9.28 | |
| Xeris Pharmaceuticals (XERS) | 7.5 | $19M | 3.2M | 5.80 | |
| Fennec Pharmaceuticals (FENC) | 7.2 | $18M | 2.9M | 6.15 | |
| Savara (SVRA) | 7.0 | $18M | 3.2M | 5.46 | |
| Vaxcyte (PCVX) | 6.8 | $17M | 290k | 58.11 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 5.4 | $13M | 1.0M | 12.89 | |
| X4 Pharmaceuticals Com New (XFOR) | 5.3 | $13M | 3.2M | 4.13 | |
| Vor Biopharma Com New (VOR) | 5.0 | $13M | 700k | 17.84 | |
| Mediwound Shs New (MDWD) | 4.8 | $12M | 749k | 16.11 | |
| Verastem Com New (VSTM) | 4.6 | $11M | 2.1M | 5.30 | |
| Celldex Therapeutics Com New (CLDX) | 4.2 | $11M | 330k | 31.72 | |
| BioCryst Pharmaceuticals (BCRX) | 3.5 | $8.8M | 923k | 9.52 | |
| Cybin Com New (HELP) | 3.0 | $7.4M | 1.5M | 4.80 | |
| Cg Oncology (CGON) | 2.7 | $6.8M | 100k | 67.68 | |
| Inspiremd (NSPR) | 2.6 | $6.4M | 3.9M | 1.63 | |
| Atea Pharmaceuticals (AVIR) | 2.5 | $6.3M | 1.2M | 5.38 | |
| Profound Medical Corp Com New (PROF) | 2.2 | $5.4M | 828k | 6.48 | |
| Miragen Therapeutics (VRDN) | 2.0 | $4.9M | 250k | 19.56 | |
| Replimune Group Call Call Option | 1.1 | $2.7M | 1.3M | 2.15 | |
| Polypid (PYPD) | 1.1 | $2.6M | 598k | 4.38 | |
| Myomo Com New (MYO) | 1.0 | $2.6M | 3.8M | 0.68 | |
| Talphera Com New (TLPH) | 1.0 | $2.5M | 3.4M | 0.75 | |
| Ovid Therapeutics (OVID) | 1.0 | $2.5M | 1.1M | 2.22 | |
| Definium Therapeutics Com Shs (DFTX) | 0.9 | $2.4M | 125k | 18.90 | |
| Onkure Therapeutics Com Cl A (OKUR) | 0.7 | $1.8M | 444k | 4.14 | |
| Lipocine Com New (LPCN) | 0.7 | $1.8M | 222k | 7.99 | |
| Neuraxis (NRXS) | 0.7 | $1.7M | 286k | 5.92 | |
| Avalo Therapeutics Com New (AVTX) | 0.4 | $1.1M | 75k | 14.93 | |
| Annexon (ANNX) | 0.4 | $1.1M | 200k | 5.54 | |
| Invesco Qqq Tr Put Put Option | 0.4 | $1.1M | 250k | 4.21 | |
| Aquestive Therapeutics (AQST) | 0.4 | $1.0M | 250k | 4.15 | |
| Spdr S&p 500 Etf Tr Put Put Option | 0.4 | $959k | 125k | 7.67 | |
| Biofrontera Com New (BFRI) | 0.4 | $942k | 1.2M | 0.81 | |
| Kura Oncology (KURA) | 0.3 | $813k | 100k | 8.13 | |
| Regentis Biomaterials Ordinary Shares (RGNT) | 0.3 | $768k | 252k | 3.06 | |
| Viridian Therapeutics Put Put Option | 0.0 | $53k | 264k | 0.20 | |
| Uniqure Nv Call Call Option | 0.0 | $0 | 296k | 0.00 | |
| Arrivent Biopharma Call Call Option | 0.0 | $0 | 109k | 0.00 |
